| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 13 Feb 2026 | 9 Feb 2026 |
| Shentracon Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter and nine month ended 31st December 2025. We wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Friday, 13th February, 2026, has, inter alia, considered and approved the unaudited standalone financial results for the quarter and nine months ended 31st December, 2025. Accordingly, we enclose herewith a copy of the said financial results as reviewed by the Audit Committee along with the Limited Review Report for the said period issued by the Statutory Auditors of the Company. The Board Meeting commenced at 05.00 p.m. and concluded at 05:40 p.m. (As Per BSE Announcement Dated on 13.02.2026) | ||
| Board Meeting | 8 Nov 2025 | 4 Nov 2025 |
| Shentracon Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2025 inter alia to consider and approve the unaudited financial results for the quarter and half year ended 30th September 2025. Approved the un-audited financial results for the quarter and half year ended 30-09-2025 (As per BSE Announcement dated on: 08.11.2025) | ||
| Board Meeting | 24 Oct 2025 | 24 Oct 2025 |
| Please find the attached Outcome of Board meeting without Intimation dated Friday, 24th October, 2025 | ||
| Board Meeting | 6 Aug 2025 | 29 Jul 2025 |
| Shentracon Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2025 inter alia to consider and approve the un-audited financial results for the quarter ended on 30-06-2025; finalize the date venue of 32nd A.G.M. along with the Notice of AGM. Approved the un-audited financial results for the 1st quarter ended June 30, 2025. Please find attached approved un-audited financial results for the 1st quarter ended on 30/06/2025. (As Per BSE Announcement Dated on :06.08.2025) | ||
| Board Meeting | 2 Jun 2025 | 2 Jun 2025 |
| Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations), we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Monday, 2nd June, 2025, has, based on the recommendation of the Nomination and Remuneration Committee appointed Ms. Vandana Gupta a qualified Company Secretary as the Company Secretary and Compliance Officer designated as Key Managerial Person of the Company with effect from 2nd June, 2025. | ||
| Board Meeting | 28 May 2025 | 28 May 2025 |
| Dear Sir/Madam, Pursuant to Regulation 30 read with Schedule III and Regulation 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Wednesday, 28th May, 2025 has: - 1. Based on the recommendation of the Nomination and Remuneration Committee appointed Ms. Kiran Satyawan Vaidya as the Chief Financial Officer (CFO) Key Managerial Person of the Company with effect from 28th May 2025. In this regard, please find attached the particulars of the disclosure required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Part A of Schedule III and SEBI Master Circular dated November 11, 2024 as Annexure A. | ||
| Board Meeting | 10 May 2025 | 30 Apr 2025 |
| Shentracon Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2025 inter alia to consider and approve the Audited Financial Results of the Company for the quarter and year ended 31st March 2025. Approved the Audited Financial Results for the quarter and year ended March 31, 2025 along with unmodified auditors report issued by statutory auditor. (As Per BSE Announcement Dated on :10.05.2025) | ||
| Board Meeting | 13 Mar 2025 | 13 Mar 2025 |
| The Board of Director of the Company, today i.e, 13.03.2025, considered and approved the allotment of 2,00,000 10% Cumulative Non-Convertible Redeemable Preference Share of Rs. 50/- each | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.